Literature DB >> 24969559

SENP2 regulated the stability of β-catenin through WWOX in hepatocellular carcinoma cell.

Qing-Feng Jiang1, Yu-Wei Tian, Quan Shen, Huan-Zhou Xue, Ke Li.   

Abstract

SUMOylation and deSUMOylation are dynamic mechanisms regulating a spectrum of protein activities. The SUMO proteases (SENP) remove SUMO conjugate from proteins, and their expression is deregulated in cancers. SENP2 has been reported to play a critical role in the control of hepatocellular carcinoma (HCC) cell growth by modulating the stability of β-catenin. However, the underlying mechanism remains largely unknown. Here, we show that the WW domain-containing oxidoreductase (WWOX), a novel inhibitor of the Wnt/β-catenin pathway, is required for stabilization of β-catenin regulated by SENP2 in HCC cells. The transcriptional level of WWOX is tightly regulated by SENP2. Moreover, knockdown of WWOX by siRNA attuned SENP2-induced β-catenin degradation and decreased SENP2-mediated HCC cell proliferation arrest. Taken together, our data suggested that WWOX is a key downstream modulator of the SENP2 tumor suppressor function in HCC cell.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24969559     DOI: 10.1007/s13277-014-2239-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  29 in total

Review 1.  Post-translational modification by SUMO.

Authors:  Zara Hannoun; Sebastian Greenhough; Ellis Jaffray; Ronald T Hay; David C Hay
Journal:  Toxicology       Date:  2010-07-30       Impact factor: 4.221

2.  SUMO-specific protease 2 in Mdm2-mediated regulation of p53.

Authors:  M Jiang; S-Y Chiu; W Hsu
Journal:  Cell Death Differ       Date:  2010-12-24       Impact factor: 15.828

Review 3.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

4.  Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma.

Authors:  Sara Del Mare; Kyle C Kurek; Gary S Stein; Jane B Lian; Rami I Aqeilan
Journal:  Am J Cancer Res       Date:  2011-04-03       Impact factor: 6.166

Review 5.  SUMO and its role in human diseases.

Authors:  Kevin D Sarge; Ok-Kyong Park-Sarge
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

6.  The expression and significance of WWOX and β-catenin in hepatocellular carcinoma.

Authors:  Yu-Pu Li; Chun-Chieh Wu; Wan-Tzu Chen; Ya-Chun Huang; Chee-Yin Chai
Journal:  APMIS       Date:  2012-07-21       Impact factor: 3.205

Review 7.  Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma.

Authors:  Mary Maluccio; Anne Covey
Journal:  CA Cancer J Clin       Date:  2012-10-15       Impact factor: 508.702

8.  Transcriptional repression of estrogen receptor α signaling by SENP2 in breast cancer cells.

Authors:  Thiziri Nait Achour; Stéphanie Sentis; Catherine Teyssier; Amandine Philippat; Annick Lucas; Laura Corbo; Vincent Cavaillès; Stéphan Jalaguier
Journal:  Mol Endocrinol       Date:  2013-01-01

9.  SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages.

Authors:  Shang-Yi Chiu; Naoya Asai; Frank Costantini; Wei Hsu
Journal:  PLoS Biol       Date:  2008-12-16       Impact factor: 8.029

10.  SENP1 and SENP2 affect spatial and temporal control of sumoylation in mitosis.

Authors:  Caelin Cubeñas-Potts; Jacqueline D Goeres; Michael J Matunis
Journal:  Mol Biol Cell       Date:  2013-09-18       Impact factor: 4.138

View more
  16 in total

1.  Analgesic-antitumor peptide inhibits the migration and invasion of HepG2 cells by an upregulated VGSC β1 subunit.

Authors:  Guili Guo; Yong Cui; Hong Chen; Lili Zhang; Mingyi Zhao; Bin Chen; Jinghai Zhang; Yanfeng Liu
Journal:  Tumour Biol       Date:  2015-09-29

Review 2.  Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.

Authors:  Jianxiang Chen; Muthukumar Rajasekaran; Kam M Hui
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-21

Review 3.  SUMOylation and phosphorylation cross-talk in hepatocellular carcinoma.

Authors:  Maria Lauda Tomasi; Komal Ramani
Journal:  Transl Gastroenterol Hepatol       Date:  2018-04-23

4.  SUMO-specific protease 2 (SENP2) functions as a tumor suppressor in osteosarcoma via SOX9 degradation.

Authors:  Hong Pei; Liang Chen; Quan-Ming Liao; Ke-Jun Wang; Shun-Guang Chen; Zheng-Jie Liu; Zhi-Cai Zhang
Journal:  Exp Ther Med       Date:  2018-10-09       Impact factor: 2.447

Review 5.  Regulation of SUMOylation Targets Associated With Wnt/β-Catenin Pathway.

Authors:  Linlin Fan; Xudong Yang; Minying Zheng; Xiaohui Yang; Yidi Ning; Ming Gao; Shiwu Zhang
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

Review 6.  Advances in the development of SUMO specific protease (SENP) inhibitors.

Authors:  Ashutosh Kumar; Kam Y J Zhang
Journal:  Comput Struct Biotechnol J       Date:  2015-03-24       Impact factor: 7.271

7.  Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.

Authors:  Alicja Mirecka; Zbigniew Morawiec; Katarzyna Wozniak
Journal:  Pathol Oncol Res       Date:  2016-05-13       Impact factor: 3.201

8.  SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.

Authors:  Chun-Ping Cui; Carmen Chak-Lui Wong; Alan Ka-Lun Kai; Daniel Wai-Hung Ho; Eunice Yuen-Ting Lau; Yu-Man Tsui; Lo-Kong Chan; Tan-To Cheung; Kenneth Siu-Ho Chok; Albert C Y Chan; Regina Cheuk-Lam Lo; Joyce Man-Fong Lee; Terence Kin-Wah Lee; Irene Oi Lin Ng
Journal:  Gut       Date:  2017-03-03       Impact factor: 23.059

9.  SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1.

Authors:  Mingyue Tan; Hua Gong; Jun Wang; Le Tao; Dongliang Xu; Erdun Bao; Zhihong Liu; Jianxin Qiu
Journal:  Sci Rep       Date:  2015-09-15       Impact factor: 4.379

10.  Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma.

Authors:  Jun Liu; Manqi Sha; Qianfeng Wang; Yong Ma; Xiaoping Geng; Yufeng Gao; Lijie Feng; Yujun Shen; Yuxian Shen
Journal:  BMC Cancer       Date:  2015-10-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.